Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differentially expressed plasmatic microRNAs in Brazilian patients with Coronavirus disease 2019 (COVID-19): preliminary results
Aline de Souza Nicoletti, Marília Berlofa Visacri, Carla Regina da Silva Correa da Ronda, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 7, pp. 6931-6943
Open Access | Times Cited: 22

Showing 22 citing articles:

Role of miRNA dysregulation in sepsis
Amanda Formosa, Paul J. Turgeon, Claúdia C. dos Santos
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 38
Role of the MicroRNAs in the Pathogenic Mechanism of Painful Symptoms in Long COVID: Systematic Review
Samuel Reyes-Long, José Luis Cortes-Altamirano, Cindy Bandala, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3574-3574
Open Access | Times Cited: 14
miRNAs as a Potential Biomarker in the COVID-19 Infection and Complications Course, Severity, and Outcome
Milena Janković, Dejan Nikolić, Ivana Novaković, et al.
Diagnostics (2023) Vol. 13, Iss. 6, pp. 1091-1091
Open Access | Times Cited: 12
Differentially‐regulated miRNAs in COVID‐19: A systematic review
Waqar Ahmad, Bushra Gull, Jasmin Baby, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 4
Open Access | Times Cited: 9
In silico identification of potential miRNAs -mRNA inflammatory networks implicated in the pathogenesis of COVID-19
Somayeh Hashemi Sheikhshabani, Zeinab Amini‐Farsani, Parastoo Modarres, et al.
Human Gene (2023) Vol. 36, pp. 201172-201172
Open Access | Times Cited: 8
Characterization of the SARS-CoV-2 Genome 3′-Untranslated Region Interactions with Host MicroRNAs
Caleb J. Frye, Caylee L. Cunningham, Mihaela‐Rita Mihailescu
ACS Omega (2024)
Open Access | Times Cited: 2
The relationship between microRNAs and COVID-19 complications
Abdollah Kebriaei, Reza Besharati, Hasan Namdar Ahmad Abad, et al.
Non-coding RNA Research (2024) Vol. 10, pp. 16-24
Open Access | Times Cited: 2
Live and let die: signaling AKTivation and UPRegulation dynamics in SARS-CoVs infection and cancer
Mariana Suaya, Gonzalo M. Sánchez, Antonella Vila, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 10
Open Access | Times Cited: 10
Single-nucleotide polymorphisms related to vitamin D metabolism and severity or mortality of COVID-19: A systematic review and meta-analysis
Carla Regina da Silva Correa da Ronda, Marília Berlofa Visacri, Júlia Tiemi Siguemoto, et al.
Gene (2024) Vol. 906, pp. 148236-148236
Closed Access | Times Cited: 1
Identification of common genes and pathways between type 2 diabetes and COVID-19
Ya Wang, Kai Li, Shuangyang Mo, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 1
Increased expression of miR-320b in blood plasma of patients in response to SARS-CoV-2 infection
Aline de Souza Nicoletti, Marília Berlofa Visacri, Carla Regina da Silva Correa da Ronda, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Host miRNAs as biomarkers of SARS-CoV-2 infection: a critical review
Kato Pollet, Nathalie Garnier, Sabine Szunerits, et al.
Sensors & Diagnostics (2022) Vol. 2, Iss. 1, pp. 12-35
Open Access | Times Cited: 8
A Comparative Analysis of MicroRNA Expression in Mild, Moderate, and Severe COVID-19: Insights from Urine, Serum, and Nasopharyngeal Samples
Raya Soltane, Nuha Almulla, Ahlam Alasiri, et al.
Biomolecules (2023) Vol. 13, Iss. 12, pp. 1681-1681
Open Access | Times Cited: 4
The biomarkers’ landscape of post-COVID-19 patients can suggest selective clinical interventions
Debora Paris, Letizia Palomba, Maria Cristina Albertini, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Non-coding RNAs: the silent regulators of health and diseases
Nishant Chakravorty
Molecular Biology Reports (2022) Vol. 49, Iss. 7, pp. 6971-6973
Open Access | Times Cited: 6
Systematic levels of IL-29 and microRNA185-5p were not associated with severe COVID-19 in the Iranian population
Omidreza Sarrafi, Ashraf Kariminik, Mohammad Kazemi Arababadi
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Next-generation sequencing profiling of miRNAs in individuals with 22q11.2 deletion syndrome revealed altered expression of miR-185-5p
Anelisa Gollo Dantas, Beatriz C. Nunes, Natália Nunes, et al.
Human Genomics (2024) Vol. 18, Iss. 1
Open Access
Circulating miRNAs in the Plasma of Post-COVID-19 Patients with Typical Recovery and Those with Long-COVID Symptoms: Regulation of Immune Response-Associated Pathways
Anna M. Timofeeva, Artem O. Nikitin, Georgy A. Nevinsky
Non-Coding RNA (2024) Vol. 10, Iss. 5, pp. 48-48
Open Access
Longitudinal transcriptome analysis reveals distinct gene expression patterns in traditional Chinese medicine syndromes of upper respiratory tract infections
Hao Zou, Can Huang, Qinqi Feng, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access
Circulatory microRNAs as potential biomarkers for different aspects of COVID-19
Mahsan Zali, Mona Sadat Larijani, Anahita Bavand, et al.
Archives of Virology (2024) Vol. 170, Iss. 1
Closed Access
Biomarkers and prognostic models for severe COVID-19 in comparison with other etiologies of sepsis
Sergey G. Sсherbak, Аndrey М. Sarana, Dmitry A. Vologzhanin, et al.
Russian Medicine (2023) Vol. 29, Iss. 4, pp. 325-348
Closed Access
Systematic levels of IL-29 and microRNA185-5p were not associated with severe COVID-19 in the Iranian population
Omidreza Sarrafi, Ashraf Kariminik, Mohammad Kazemi Arababadi
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top